Registries and databases—A European perspective
نویسندگان
چکیده
منابع مشابه
The need for European Registries in inherited cardiomyopathies.
We read with interest the clinical perspective ‘Is prophylaxis the best use of the ICD?’ by Nisam and Farre. There is no doubt that ICDs save lives and are certainly a great advance in the treatment of heart disease in this century. The MADIT-II results were published recently and are likely to bring about an exponential increase in the use of the device. However, some of the aspects of MADIT-I...
متن کاملTowards a European platform for Rare Diseases Registries
The Joint Research Centre (JRC) is a Directorate-General (DG) of the European Commission (EC), it was established in 1957 and its mission is to provide independent, evidence-based scientific and technical support throughout the EU policy cycle. Health is a key European policy area and research on Rare Diseases (RD) is identified as a priority in both the Commission Communication on RD: Europe’s...
متن کاملA European Perspective
Traditionally, serious lower respiratory tract infections (LRTIs) are treated in hospital and with parenteral antibiotics. During the past decade, there has been an impetus to reduce the overall cost of antimicrobial therapy. The availability of new oral antibiotics with superior pharmacoki¬ netics profiles and safety has enabled clinicians increasingly to consider their use in managing serious...
متن کاملPatient recruitment--European perspective.
A considerable number of patients have to be recruited in a clinical trial to obtain solid results. In pediatric studies, patient recruitment is frequently problematic. In the simple common childhood illnesses, the number of recruitable patients is certainly large, but they may be hard to reach, and the imbalance between potential benefit and inconvenience of participation may reduce motivation...
متن کاملTherapeutic orphans: European perspective.
There are several factors to be considered when facing the problem of therapeutic orphans. First, there is the scientific one. We are all convinced that there is much need for more data concerning the use of drugs in children, infants, and neonates. Second, there is a regulatory factor involving political and technical institutions. Finally, we have to consider the economic interest of the phar...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Haemophilia
سال: 2020
ISSN: 1351-8216,1365-2516
DOI: 10.1111/hae.13920